NCT04530175 (MARC) is a clinical trial of blood sampling in End Stage Renal Disease, sponsored by University Hospital, Clermont-Ferrand.

Who is sponsoring NCT04530175?

NCT04530175 is sponsored by University Hospital, Clermont-Ferrand.

What drugs are being tested in NCT04530175?

Interventions in NCT04530175: blood sampling.

What condition does NCT04530175 study?

NCT04530175 studies End Stage Renal Disease.

Is NCT04530175 still recruiting?

NCT04530175 is currently completed. Last updated 9 February 2022.

Last reviewed 2022-02-09 · How we verify

NCT04530175: MARC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Modeling of Regional Citrate Anticoagulation With a Dialysate Containing Calcium in Intermittent Hemodialysis (MARC)

Completed Last updated 9 February 2022

What this trial tests

trial testing blood sampling in End Stage Renal Disease in 30 participants. Completed in 7 July 2021.

Timeline

2 February 2021

Primary endpoint
7 July 2021

7 July 2021

Quick facts

Lead sponsor	University Hospital, Clermont-Ferrand
Status	Completed
Study type	OBSERVATIONAL
Enrollment	30
Start date	2 February 2021
Primary completion	7 July 2021
Estimated completion	7 July 2021
Sites	1 location across France

Drugs / interventions tested

blood sampling — full drug profile →

Conditions studied

End Stage Renal Disease — all drugs for End Stage Renal Disease →

Sponsor

University Hospital, Clermont-Ferrand

Who can join

18 and older, any sex, with End Stage Renal Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary purpose of this study is to validate a mathematical modeling of treatment by intermittent hemodialysis using regional citrate anticoagulation with a dialysate containing calcium

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Deciphering simplified regional anticoagulation with citrate in intermittent hemodialysis: a clinical and computational study.
Aniort J, Richard F, Thouy F, Le Guen L, et al · · 2024 · cited 1× · PMID 39187537 · DOI 10.1038/s41598-024-70708-9

Verify or expand the search:

Other trials of blood sampling

Trials testing the same drug.

NCT07467109 — A Study to Evaluate the Safety and Efficacy of Intracranial Venous Blood Sampling for Liquid Biopsy in the Diagnosis of · not yet recruiting
NCT07347613 — Long-term Follow-up of Diabetic Patients From the GLUTADIAB Study · not yet recruiting
NCT07472387 — Impact of Androgen Signaling on the Composition of the Immune Microenvironment in Glioblastomas · NA · not yet recruiting
NCT07477769 — Lymphocyte Phenotype of Autosomal Recessive Congenital Ichthyoses Mutated NIPAL4 (Nipal4-nEDD) · not yet recruiting
NCT07236177 — B-GLUCANCER2 : A Pilot Study Evaluating a New Method for Cancer Detection by Measuring the Activity of Different Glycosi · EARLY_PHASE1 · recruiting

Other recruiting trials for End Stage Renal Disease

Currently open trials in the same condition.

NCT06257134 — Impact on Quality of Life of Symptoms Routine E-monitoring Among Dialysis Patients. · NA · recruiting
NCT06310161 — Light Therapy in End Stage Kidney Disease · NA · recruiting
NCT07360938 — Drug Interaction Potential of Pro-Inflammatory Conditions · recruiting
NCT06422871 — PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis · recruiting
NCT06861816 — Ventilatory Functions and Physical Intolerance in ESRD Adolescents: Response to Program of Walking With Dogs · NA · recruiting

Other University Hospital, Clermont-Ferrand trials

Trials by the same sponsor.

NCT07179276 — Veno-arterial Carbon Dioxide Partial Pressure Difference (CO2gap) for Early Resuscitation of Septic Shock · NA · recruiting
NCT07476768 — PAINDYS_Characterizing Pain in Fibrous Dysplasia of Bone/McCune-Albright Syndrome: an Exploratory Pilot Study · NA · not yet recruiting
NCT07439146 — Risk of Pneumonia in Intubated Patients in Emergency Situations · not yet recruiting
NCT07427537 — Exploration of Circulating microRNAs as Biomarkers of Chemo-induced Peripheral Neuropathy: a Study in Cancer Patients · NA · recruiting
NCT07330856 — Evaluation of Treatments for Dry or Productive Cough · Phase 4 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04530175 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Clermont-Ferrand
Last refreshed: 9 February 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04530175.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing